GOSSAMER BIO INC (GOSS) Stock Income Statement
NASDAQ:GOSS - Nasdaq - US38341P1021 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 114.70M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 174.62M | 173.76M | 218.52M | 216.04M | 210.58M | |||
| Research and Development | 138.49M | 135.30M | 170.92M | 170.27M | 160.85M | |||
| Selling, General, and Administrative Expenses | 36.13M | 38.45M | 45.81M | 44.08M | 48.33M | |||
| Operating Income | -59.92M | -173.76M | -218.52M | -216.04M | -210.58M | |||
| Interest Income/Expense | -9.74M | -11.51M | -12.30M | -18.68M | -9.22M | |||
| Other Income/Expense | 14.02M | 15.46M | 1.51M | 800.00K | -170.00K | |||
| Non Recurring Items | 0.00 | -10.00M | -70.00K | -80.00K | -23.38M | |||
| Income Before Taxes | -55.63M | -179.82M | -229.38M | -234.00M | -243.36M | |||
| Income Tax | 893.00K | N/A | N/A | N/A | N/A | |||
| Net Income | -56.53M | -179.82M | -229.38M | -234.00M | -243.36M | |||
| EBITDA | -59.09M | -172.15M | -216.69M | -214.30M | -209.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.25 | -1.18 | -2.71 | -3.13 | -3.55 | |||
| Non GAAP EPS | -0.26 | -1.39 | -2.74 | -3.12 | -3.55 | |||
| Statistics | ||||||||
| Profit Margin | -49.28% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -52.24% | N/A | N/A | N/A | N/A | |||
All data in USD